Akums Drugs & Pharmaceuticals Share Price
823.40+39.70 (+5.07%)
+72.80% past 1 Year
Corporate filings & documents
Announcements
Intimation of Schedule of Investors/Analysts Meet
4 days agoIntimation of Schedule of Investors/Analysts Meet
4 days agoIntimation of ESG Rating
2 weeks agoIntimation of ESG Rating
2 weeks agoIntimation of Schedule of the Investors/Analysts Meet
3 weeks agoIntimation of Schedule of the Investors/Analysts Meet
3 weeks agoAkums Drugs and Pharmaceuticals Limited has informed the exchange about an update on schedule of the Investors/ Analysts Meet to be held on August 25 2026
3 weeks agoAkums Drugs and Pharmaceuticals Limited has informed the exchange about an update on schedule of the Investors/ Analysts Meet to be held on August 25 2026
3 weeks agoIntimation of Schedule of the Investors/Analysts Meet
1 month agoIntimation of Schedule of the Investors/Analysts Meet
1 month agoTranscript of Investors/Analysts conference call for the unaudited financial results of Q1 FY 27
1 month agoTranscript of Investors/Analysts conference call for the unaudited financial results of Q1 FY 27
1 month agoIntimation of Schedule of the Investors/Analysts Meet to be held on August 14 2026
1 month agoIntimation of Schedule of the Investors/Analysts Meet to be held on August 14 2026
1 month agoLink of audio recording of Investors/Analysts Conference Call
1 month agoLink of audio recording of Investors/Analysts Conference Call
1 month agoNewspaper Publication
1 month agoNewspaper Publication
1 month agoMonitoring Agency Report for the quarter ended June 30 2026
1 month agoMonitoring Agency Report for the quarter ended June 30 2026
1 month agoInvestor Presentation
1 month agoInvestor Presentation
1 month agoPress Release
1 month agoPress Release
1 month agoUn-audited Financial Results for the Quarter ended 30th June 2026
1 month agoUn-audited Financial Results for the Quarter ended 30th June 2026
1 month agoUn-audited Financial Results for the Quarter ended 30th June 2026
1 month agoUn-audited Financial Results for the Quarter ended 30th June 2026
1 month agoIntimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27
1 month agoIntimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27
1 month agoIntimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27
1 month agoIntimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27
1 month agoAkums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results for the quarter ended on 30th June 2026
1 month agoAkums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results for the quarter ended on 30th June 2026
1 month agoIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- Acquisition of Oriflame Indias Manufacturing Business
1 month agoVoting Results and Scrutinizers Report of the 22nd Annual General Meeting
2 months agoVoting Results and Scrutinizers Report of the 22nd Annual General Meeting
2 months agoProceedings of the 22nd Annual General Meeting of the Company
2 months agoProceedings of the 22nd Annual General Meeting of the Company
2 months agoCertificate pursuant to Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations 2018
2 months agoCertificate pursuant to Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations 2018
2 months agoUpdate on penalty imposed by the Deputy Commissioner of State Tax Gujarat on Maxcure Nutravedics Limited wholly owned subsidiary of the Company
2 months agoUpdate on penalty imposed by the Deputy Commissioner of State Tax Gujarat on Maxcure Nutravedics Limited wholly owned subsidiary of the Company
2 months agoClosure of Trading Window
2 months agoClosure of Trading Window
2 months agoNewspaper Advertisements of the 22nd Annual General Meeting of the Company
3 months agoNewspaper Advertisements of the 22nd Annual General Meeting of the Company
3 months agoNotice and Integrated Annual Report for the Financial Year 2025-26 to those members who have not registered their e-mail IDs
3 months agoNotice and Integrated Annual Report for the Financial Year 2025-26 to those members who have not registered their e-mail IDs
3 months agoBusiness Responsibility and Sustainability Reporting for the FY 2025-26
3 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation